What Researchers Did
Researchers conducted a systematic review to evaluate the benefits and adverse effects of hyperbaric oxygen treatment for cerebral palsy.
What They Found
The review identified two randomized controlled trials and four observational studies, with the best evidence showing similar 5-6% improvements in motor function for both hyperbaric oxygen therapy at 1.75 atmospheres and pressurized room air at 1.3 atmospheres. Other outcomes also indicated no difference between HBOT and room air, though adverse events like seizures and the need for ear pressure equalization tubes were reported with HBOT, but their incidence was unclear.
What This Means for Canadian Patients
Canadian patients with cerebral palsy considering hyperbaric oxygen therapy should be aware that current evidence suggests it may not offer greater motor function benefits than pressurized room air. Patients should discuss these findings with their healthcare providers to make informed decisions about treatment options.
Canadian Relevance
This systematic review did not include any specific Canadian studies or data.
Study Limitations
A key limitation was the insufficient evidence to fully clarify the benefits and adverse effects of hyperbaric oxygen therapy for cerebral palsy, highlighting the need for further comparative research.